Actively Recruiting

Phase 2
Age: 18Years - 50Years
All Genders
Healthy Volunteers
NCT06806202

Warm Versus Conventional 2% Lignocaine for IANB Efficacy

Led by Armed Forces Institute of Dentistry, Pakistan · Updated on 2025-02-03

200

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study compares the anesthetic efficacy of warm versus conventional 2% lignocaine for inferior alveolar nerve block in mandibular molars, evaluating success rates and onset time.

CONDITIONS

Official Title

Warm Versus Conventional 2% Lignocaine for IANB Efficacy

Who Can Participate

Age: 18Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Permanent teeth with acutely inflamed pulp without swelling or draining sinus
  • Carious mandibular molars
  • Patients aged 18 to 50 years
  • Systemically healthy patients
  • Patients willing to attend follow-up visits and provide written consent
Not Eligible

You will not qualify if you...

  • Patients currently taking painkillers or antibiotics before the procedure
  • Teeth with calcified canals or previously treated teeth
  • Pregnant or breastfeeding women
  • Patients who are immunocompromised, anxious, or mentally handicapped
  • Patients allergic to lignocaine
  • Teeth that are non-vital or necrotic

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Armed Forces Institute Of Dentistry

Rawalpindi, Punjab Province, Pakistan, 46000

Actively Recruiting

Loading map...

Research Team

M

Maha Ali Mirza, BDS

CONTACT

K

Kanza Zafar, BDS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here